ES2146235T3 - Celulas endoteliales transformadas. - Google Patents

Celulas endoteliales transformadas.

Info

Publication number
ES2146235T3
ES2146235T3 ES93924544T ES93924544T ES2146235T3 ES 2146235 T3 ES2146235 T3 ES 2146235T3 ES 93924544 T ES93924544 T ES 93924544T ES 93924544 T ES93924544 T ES 93924544T ES 2146235 T3 ES2146235 T3 ES 2146235T3
Authority
ES
Spain
Prior art keywords
cells
endothelial cells
present
ikb
stimulus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93924544T
Other languages
English (en)
Inventor
Fritz H Bach
Martin Rainer De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of ES2146235T3 publication Critical patent/ES2146235T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Environmental Sciences (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Animal Husbandry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SE PUEDEN PREPARAR CELULAS ENDOTELIALES QUE PRESENTAN UNA PROTEINA QUE TIENE ACTIVIDAD IKB PARA QUE LA ACTIVACION DE NFKB DE LAS CELULAS ESTE SUBSTANCIALMENTE BLOQUEADA ALTERANDO EL MATERIAL GENETICO DE LAS CELULAS PARA QUE LA ACTIVIDAD IKB SE PRESENTE CONTINUAMENTE, INMEDIATAMENTE DESPUES DE QUE LAS CELULAS ENDOTELIALES ACTIVAN UN ESTIMULO O A PETICION EN RESPUESTA A UN ESTIMULO EXTERNO PREDETERMINADO V. G. INTRODUCIENDO IKB HETEROLOGO QUE CODIFICA SECUENCIAS O PROMOTORES EN LAS CELULAS. LOS ORGANOS Y TEJIDOS QUE COMPRENDEN TALES CELULAS ENDOTELIALES SON UTILES EN TRASPLANTES V. G. EXOTRANSPLANTES, PORQUE SON VENTAJOSAMENTE MENOS SUSCEPTIBLES DE RECHAZO.
ES93924544T 1992-11-02 1993-10-29 Celulas endoteliales transformadas. Expired - Lifetime ES2146235T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929222931A GB9222931D0 (en) 1992-11-02 1992-11-02 Organic compounds

Publications (1)

Publication Number Publication Date
ES2146235T3 true ES2146235T3 (es) 2000-08-01

Family

ID=10724398

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93924544T Expired - Lifetime ES2146235T3 (es) 1992-11-02 1993-10-29 Celulas endoteliales transformadas.

Country Status (16)

Country Link
EP (1) EP0669977B1 (es)
JP (1) JPH08502653A (es)
KR (1) KR950704477A (es)
AT (1) ATE192492T1 (es)
AU (1) AU680636B2 (es)
CA (1) CA2143489A1 (es)
DK (1) DK0669977T3 (es)
ES (1) ES2146235T3 (es)
FI (1) FI952088A7 (es)
GB (1) GB9222931D0 (es)
GR (1) GR3033600T3 (es)
NO (1) NO951628L (es)
NZ (1) NZ257539A (es)
PT (1) PT669977E (es)
RU (1) RU2164415C2 (es)
WO (1) WO1994010305A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2726005B1 (fr) * 1994-10-10 1997-01-03 Adim Lignees immortalisees de cellules endotheliales cerebrales et leurs applications au traitement de differents troubles ou maladies primaires et secondaires neurologiques ou psychiatriques
WO1996030532A1 (en) * 1995-03-24 1996-10-03 Novartis Ag Gene therapy for transplantation and inflammatory or thrombotic conditions
WO1996032412A1 (en) * 1995-04-13 1996-10-17 Chugai Seiyaku Kabushiki Kaisha PEPTIDE SUPPRESSING IxBα PHOSPHORYLATION
JPH0959151A (ja) * 1995-08-24 1997-03-04 Kao Corp ＮＦ−κＢ活性化抑制剤
EP0779361A3 (en) 1995-12-15 1999-11-10 F. Hoffmann-La Roche Ag Truncated form of inhibitory kappa B protein (1kB), recombinant production and uses thereof
AU1873097A (en) * 1996-02-14 1997-09-02 New England Deaconess Hospital Corporation Gene therapy of entothelial cells with anti-apoptotic proteins for transplantation and inflammatory conditions
AU2001231009A1 (en) 2000-01-21 2001-07-31 Beth Israel Deaconess Medical Center Use of pro-apoptotic factors in treatment of atherosclerosis
EP1702062A2 (en) * 2003-06-11 2006-09-20 Jan Remmereit Differentiation of stem cells for therapeutic use
TW201120210A (en) 2009-11-05 2011-06-16 Hoffmann La Roche Glycosylated repeat-motif-molecule conjugates
BR112013024781B1 (pt) 2011-04-01 2021-09-08 Chugai Seiyaku Kabushiki Kaisha Métodos de produção de um anticorpo e de uma composição farmacêutica

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989008147A1 (en) * 1988-03-01 1989-09-08 Whitehead Institute For Biomedical Research ACTIVITION OF NF-kB PRECURSOR
ES2096750T3 (es) * 1990-10-31 1997-03-16 Somatix Therapy Corp Vectores retroviricos utiles para la terapia genica.

Also Published As

Publication number Publication date
AU680636B2 (en) 1997-08-07
FI952088L (fi) 1995-05-02
NO951628L (no) 1995-07-03
EP0669977B1 (en) 2000-05-03
FI952088A0 (fi) 1995-05-02
CA2143489A1 (en) 1994-05-11
GB9222931D0 (en) 1992-12-16
AU5440494A (en) 1994-05-24
EP0669977A1 (en) 1995-09-06
NZ257539A (en) 1996-08-27
FI952088A7 (fi) 1995-05-02
PT669977E (pt) 2000-08-31
ATE192492T1 (de) 2000-05-15
NO951628D0 (no) 1995-04-28
KR950704477A (ko) 1995-11-20
GR3033600T3 (en) 2000-09-29
JPH08502653A (ja) 1996-03-26
WO1994010305A1 (en) 1994-05-11
RU2164415C2 (ru) 2001-03-27
DK0669977T3 (da) 2000-08-07

Similar Documents

Publication Publication Date Title
ES2146235T3 (es) Celulas endoteliales transformadas.
DE69600011D1 (de) Verwendung von Derivaten des Melanocyte-stimulierenden Hormons vom Typ alpha zur Stimulierung des Haarwachstums
DE69306063D1 (de) Verwendung von L-2-Oxothiazolidin-4-Carboxylatestern zur Herstellung eines Arzneimittels zur Stimulierung der intracellulären Glutathionsynthese
ES2083384T3 (es) Gen de proteina cristal insecticida sintetico.
DK270088A (da) Transdermal terapeutisk system, samt anvendelse og fremstilling deraf
DE68922602D1 (de) Polypeptide mit hormonwachstumsbefreiender wirkung.
ES2151921T3 (es) Analogo de dolastatina.
ES2151607T3 (es) Factor 12 de crecimiento y de diferenciacion.
DE69007964D1 (de) Verwendung von Thrombospondin zur Beschleunigung der Wundheilung.
FI944841L (fi) Öljyonteloproteiinit korkea-arvoisten peptidien kantajina kasveissa
DE69219622D1 (de) Herstellung von optisch aktiven aliphatischen carbonsäuren
HUP9900506A2 (hu) Protrombinszármazékok
YU49138B (sh) Proteinski derivat humane lipaze stimulisane žučnom soli
DE69112192D1 (de) Antiherpes-Castanosperminester.
ES2061218T3 (es) Composiciones farmaceuticas estabilizadas.
DK0671909T3 (da) Syndecanstimulering af cellulær differentiering
DE59100964D1 (de) Verwendung von Zink-Calciumhydroxid, Lecithin und PAO zur Adjuvierung von Antigenlösungen und auf diese Weise adjuvierte Antigenlösungen.
DE69323299D1 (de) Treibmittelzusammensetzung, herstellung von schaumstoff mittels dieser zusammensetzung und daraus hergestellte schaumstoffe
SE7705812L (sv) Farmaceutiska ogonberedningar med langsam utsondring, innehallande kollagener samt sett for framstellning derav
DE69804674D1 (de) Liposomen mit mehrfach verzweigten peptidkonstruktionen zur verwendung gegen hiv
MX9307320A (es) Proteina substancialmente pura para la inhibicion de la melanogenesis en celulas pigmentarias, metodo para su produccion y metodo para el control de la melanogenesis en celulas pigmentarias.
FI891695A7 (fi) Lohen kasvuhormoonin ilmentäminen sukuun Pichia kuuluvassa metylotroofisessa hiivassa
ATE276661T1 (de) Verfahren zur bekämpfung von motten und schadinsekten
ES2103802T3 (es) Factor de crecimiento en relacion con transplantes artificiales.
Dickey The Enclosure

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 669977

Country of ref document: ES